SELLAS Life Sciences Group, Inc.
SLSUnited States
63 filed reports · 753 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
63 reports · Jun 2011 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 4 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 45 | 5,804 | Jun 2011 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 14 | 4,704 | Dec 2011 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 2 | 204 | Jun 2011 to Sep 2013 |
| Annual · 10-K/ASEC EDGAR | 1 | 401 | Dec 2015 |
| Current · 8-KSEC EDGAR | 1 | 2 | Jun 2015 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 11, 2026 | 204 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 12, 2026 | 138 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 19, 2026 | 378 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 12, 2025 | 132 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 12, 2025 | 96 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 13, 2025 | 97 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 20, 2025 | 256 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 13, 2024 | 117 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 13, 2024 | 102 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 14, 2024 | 110 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 28, 2024 | 276 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 9, 2023 | 120 | Open |
Financial data
753 concepts · 11,115 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial752 concepts · 11,113 facts · Dec 2006 to Jun 2026
- Cash and cash equivalents at carrying value81 · Jun 2010 to Jun 2026
- Net income loss81 · Jun 2010 to Jun 2026
- Common stock par or stated value per share80 · Dec 2010 to Jun 2026
- Common stock shares outstanding80 · Dec 2010 to Jun 2026
- Increase decrease in accounts payable80 · Sep 2010 to Jun 2026
- Increase decrease in accrued liabilities80 · Sep 2010 to Jun 2026
- Net cash provided by used in financing activities80 · Sep 2010 to Jun 2026
- Net cash provided by used in operating activities80 · Sep 2010 to Jun 2026
- Share based compensation80 · Sep 2010 to Jun 2026
- Common stock shares authorized79 · Dec 2010 to Jun 2026
- Accounts payable current78 · Dec 2010 to Jun 2026
- Accrued liabilities current78 · Dec 2010 to Jun 2026
- Additional paid in capital common stock78 · Dec 2010 to Jun 2026
- Assets78 · Dec 2010 to Jun 2026
- Assets current78 · Dec 2010 to Jun 2026
- Common stock shares issued78 · Dec 2010 to Jun 2026
- Common stock value78 · Dec 2010 to Jun 2026
- Deposits assets noncurrent78 · Dec 2010 to Jun 2026
- Goodwill (US GAAP)78 · Dec 2010 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets78 · Dec 2010 to Jun 2026
- Liabilities78 · Dec 2010 to Jun 2026
- Liabilities and stockholders equity78 · Dec 2010 to Jun 2026
- Liabilities current78 · Dec 2010 to Jun 2026
- Preferred stock par or stated value per share78 · Dec 2010 to Jun 2026
Guidance1 concepts · 2 facts · Aug 2015
- Revenue Guidance2 · Aug 2015
Segments
Figures broken down by business line, region, product or another axis the company reports on.
No segment breakdowns.
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.